| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/19/2012 | WO2012009510A1 Azaindazole compounds |
| 01/19/2012 | WO2012009472A2 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes) |
| 01/19/2012 | WO2012009134A1 Crth2 modulators |
| 01/19/2012 | WO2012008508A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012007926A1 Substituted imidazoquinoline derivatives as kinase inhibitors |
| 01/19/2012 | WO2012007539A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | WO2012007409A1 N-substituted pyrrolidines |
| 01/19/2012 | WO2012007367A1 New azacyclic compounds |
| 01/19/2012 | WO2012007345A2 Substituted imidazo[1,2-a]pyrimidines and -pyridines |
| 01/19/2012 | WO2012007008A1 Inhibitors of hdme |
| 01/19/2012 | WO2012007007A1 Inhibitors of hdme |
| 01/19/2012 | WO2012006953A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/19/2012 | WO2011109551A3 Compounds that modulate intracellular calcium |
| 01/19/2012 | US20120016117 Indazolepropionic acid amide compound |
| 01/19/2012 | US20120015993 Novel Pharmaceutical Forms, and Methods of Making and Using the Same |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015975 Fused heterocyclic compound and use thereof |
| 01/19/2012 | US20120015974 Imidazopyridine inhibitors of iap |
| 01/19/2012 | US20120015972 Indolizine derivative and use thereof for medical purposes |
| 01/19/2012 | US20120015970 New azacyclic compounds |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015942 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015941 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015930 Substituted imidazoheterocycle derivatives |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015925 Novel benzothiazepine and benzothiepine compounds |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120015866 Prodrugs of Heteraromatic Compounds |
| 01/19/2012 | US20120014914 Inhibitors of serine proteases, particularly hcv ns3-ns4a proteases |
| 01/19/2012 | US20120014906 Organic compounds |
| 01/19/2012 | US20120013244 Organic luminescent medium |
| 01/19/2012 | US20120012794 Bridged Pyridoquinazoline or Phenanthroline Compounds and Organic Semiconducting Material Comprising That Compound |
| 01/19/2012 | CA2805608A1 Substituted imidazoquinoline derivatives as kinase inhibitors |
| 01/19/2012 | CA2804970A1 Spirocyclic compounds |
| 01/19/2012 | CA2804845A1 Substituted imidazo[1,2-a]pyrimidines and -pyridines |
| 01/19/2012 | CA2804744A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | CA2802528A1 New azacyclic compounds |
| 01/19/2012 | CA2800971A1 Chemical compounds |
| 01/19/2012 | CA2771928A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/18/2012 | EP2407458A1 Metal complex compound and organic light emitting diode device including the same |
| 01/18/2012 | EP2406262A1 Prodrug forms of kinase inhibitors and their use in therapy |
| 01/18/2012 | EP2406261A1 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-one derivatives, method for preparing same, and therapeutic uses thereof |
| 01/18/2012 | EP2406260A1 Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases |
| 01/18/2012 | EP2406259A1 Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases |
| 01/18/2012 | EP2406258A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 01/18/2012 | EP2405756A1 Inhibitors of akt activity |
| 01/18/2012 | EP2300472B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/18/2012 | EP2195317B1 2,3-substituted azaindole derivatives for treating viral infections |
| 01/18/2012 | EP1979348B1 Anti-viral compounds |
| 01/18/2012 | EP1656373B1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 01/18/2012 | CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/18/2012 | CN102325772A Ring compound |
| 01/18/2012 | CN102325771A Imidazo [1, 2 -a] pyridines as jnk modulators |
| 01/18/2012 | CN102325770A Piperidine derivatives useful as orexin antagonists |
| 01/18/2012 | CN102325755A Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds |
| 01/18/2012 | CN102325754A Cyclic compound having hetero atom |
| 01/18/2012 | CN102325452A 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient |
| 01/18/2012 | CN102321088A Novel anti-schistosomiasis compound |
| 01/18/2012 | CN102321085A Star molecule of truxene-perylene-series derivative and preparation method thereof |
| 01/18/2012 | CN102321084A Method for synthesizing benzo[c]pyridine[4,3,2-mn]acridine-8-one |
| 01/18/2012 | CN102321083A New anhydrous moxifloxacin hydrochloride crystal F and preparation method thereof |
| 01/18/2012 | CN102321082A Naphthyridinone carboxylic acid compound and preparation method thereof |
| 01/18/2012 | CN102320981A Chiral intermediate (S)-1-cyclobutyl ethylamine hydrochloride as well as preparation method and application thereof |
| 01/18/2012 | CN101238123B Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/17/2012 | US8097727 1-[4-(4-chloro-2-methyl-3H-imidazo[4,5-c]pyridin-3-ylmethyl)phenyl]-3-(2-fluoro-5-trifluoromethylphenyl)urea; antitumor, antiinflammatory agent, autoimmune diseases; kinase signal transduction (tyrosine, Raf) mediated diseases: solid tumors, leukemia, psoriasis, arthritis, endometriosis, |
| 01/17/2012 | US8097638 Pyridines for treating injured mammalian nerve tissue |
| 01/17/2012 | US8097634 Azacyclic derivatives |
| 01/17/2012 | US8097628 Compounds |
| 01/17/2012 | US8097620 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 01/17/2012 | US8097617 Organic compounds |
| 01/17/2012 | CA2611032C 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 01/12/2012 | WO2012006419A2 Pro-neurogenic compounds |
| 01/12/2012 | WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 01/12/2012 | WO2012005312A1 Process for preparation of trisubstituted indazoleacrylamide derivatives |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012005009A1 Imidazopyridine derivatives and organic electroluminescent elements containing same |
| 01/12/2012 | WO2012004802A1 Continuous flow process for the preparation of sulphoxide compounds |
| 01/12/2012 | WO2012004732A1 Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | WO2012004731A1 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
| 01/12/2012 | WO2012004299A1 Tetrahydro-pyrido-pyrimidine derivatives |
| 01/12/2012 | WO2012004212A1 Heterocyclic antiviral compounds |
| 01/12/2012 | WO2012003912A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | WO2012003576A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/12/2012 | WO2011123678A3 Substituted benzo-pyrido-triazolo-diazepine compounds |
| 01/12/2012 | WO2011112731A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | US20120010414 Glycine transporter inhibiting substances |
| 01/12/2012 | US20120010402 CGRP Receptor Antagonists |
| 01/12/2012 | US20120010235 N-substituted pyrrolidines |
| 01/12/2012 | US20120010233 Methods and compositions to inhibit edema factor and adenylyl cyclase |
| 01/12/2012 | US20120010223 Isothiazolo-pyrimidinedione derivatives as trpai modulators |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010220 Spiroindolinepiperidine derivatives |
| 01/12/2012 | US20120010209 IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS |
| 01/12/2012 | US20120010206 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/12/2012 | US20120010204 Phthalazinone Derivatives |